Cong Xu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Cancer-related molecular mechanisms research 9
- Co-authors
- Qibiao WuWen DiElaine Lai‐Han LeungXinbing SuiXing‐Xing FanZebo JiangYa‐Jia XieXuan‐Run Wang
- Journals
- Pharmacological Research (5 papers)Journal of Cancer (5 papers)Cancer Letters (3 papers)Frontiers in Immunology (2 papers)Journal of Drug Delivery Science and Technology (2 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Cong Xu
71 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 312
- Immunology 249
- Oncology 303
- Molecular Biology 722
- Biomaterials 118
Countries citing papers authored by Cong Xu
This map shows the geographic impact of Cong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Xu more than expected).
Fields of papers citing papers by Cong Xu
This network shows the impact of papers produced by Cong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Xu. The network helps show where Cong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 9 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 18 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 23 | |
| 13 | 2021 | 22 | |
| 14 | Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer Hit paper breakdown → | 2021 | 177 |
| 15 | 2020 | 89 | |
| 16 | 2019 | 20 | |
| 17 | 2019 | 18 | |
| 18 | 2018 | 9 | |
| 19 | 2018 | 18 | |
| 20 | 2017 | 23 |
About Cong Xu
Cong Xu is a scholar working on Cancer Research, Toxicology, Pharmacology, Oncology and Immunology, having authored 78 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Pharmacological Effects of Natural Compounds (6 papers), Conducting polymers and applications (6 papers), RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (5 papers), Copper-based nanomaterials and applications (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Cancer Research (312 citations), Immunology (249 citations), Oncology (303 citations), Molecular Biology (722 citations) and Biomaterials (118 citations). Cong Xu has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Qibiao Wu, Wen Di, Elaine Lai‐Han Leung, Xinbing Sui, Xing‐Xing Fan, Zebo Jiang, Ya‐Jia Xie, Xuan‐Run Wang, Huaiguo Xue and Yizhong Zhang. Their work appears in journals such as Pharmacological Research, Journal of Cancer, Cancer Letters, Frontiers in Immunology and Journal of Drug Delivery Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.